A breakthrough in early cancer detection
Our technology is supported by evidence from our population-scale clinical study program, believed to be the largest of its kind.
Transparency and sharing our learnings with the broader clinical and scientific community is of the utmost importance. This is why we publish manuscripts in a variety of peer-reviewed journals and present at medical conferences around the world to communicate our findings.
GRAIL is committed to helping fund innovative and impactful education to meet the needs of practicing healthcare professionals and the communities of care that they manage within our areas of interest.